Denali Capital Acquisition Corp. Class A
Why Robinhood?
You can watch DNQAF and buy or sell other stocks, ETFs, and their options commission-free!About DNQAF
Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
DNQAF Key Statistics
Stock Snapshot
The current Denali Capital Acquisition Corp. Class A(DNQAF) stock price is $12.05, with a market capitalization of 2.77B. The stock trades at a price-to-earnings (P/E) ratio of -8.12.
On 2026-04-16, Denali Capital Acquisition Corp. Class A(DNQAF) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Denali Capital Acquisition Corp. Class A(DNQAF) stock has reached 0, versus its average volume of 0.44.
Over the past 52 weeks, Denali Capital Acquisition Corp. Class A(DNQAF) stock has traded between a high of $23.00 and a low of $4.50.
Over the past 52 weeks, Denali Capital Acquisition Corp. Class A(DNQAF) stock has traded between a high of $23.00 and a low of $4.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.